{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:17:48Z","timestamp":1774930668353,"version":"3.50.1"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,15]]},"DOI":"10.2146\/ajhp160219","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T06:40:13Z","timestamp":1496904013000},"page":"898-903","source":"Crossref","is-referenced-by-count":3,"title":["Randomized controlled trial of different aspirin regimens for reduction of niacin-induced flushing"],"prefix":"10.1093","volume":"74","author":[{"given":"Sahil S.","family":"Banka","sequence":"first","affiliation":[{"name":"Department of Cardiology, Hahnemann University Hospital, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosy","family":"Thachil","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mount Sinai Hospital, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Levine","sequence":"additional","affiliation":[{"name":"University of Saint Joseph School of Pharmacy, West Hartford, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Massachusetts General Hospital, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haytham","family":"Kaafarani","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA, and Department of Surgery, Massachusetts General Hospital, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarone","family":"Lee","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA, and Departments of Emergency Medicine and Surgery, Massachusetts General Hospital, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041103305396400_b1-0740898","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2796.2005.01528.x","article-title":"Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review","volume":"258","author":"Carlson","year":"2005","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t2019041103305396400_b2-0740898","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J Am Coll Cardiol"},{"issue":"6A","key":"key\n\t\t\t\t2019041103305396400_b3-0740898","doi-asserted-by":"crossref","first-page":"22C","DOI":"10.1016\/j.amjcard.2006.11.018","article-title":"Safety considerations with niacin therapy","volume":"99","author":"Guyton","year":"2007","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019041103305396400_b4-0740898","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1368-5031.2006.00957.x","article-title":"Clinical evidence for use of acetyl salicylic acid in control of flushing related to nicotinic acid treatment","volume":"60","author":"Oberwittler","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"12A","key":"key\n\t\t\t\t2019041103305396400_b5-0740898","doi-asserted-by":"crossref","first-page":"74U","DOI":"10.1016\/S0002-9149(98)00731-0","article-title":"Efficacy and safety of an extended-release niacin (Niaspan): a long-term study","volume":"82","author":"Capuzzi","year":"1998","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019041103305396400_b6-0740898","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1185\/030079907X199637","article-title":"Validation of a questionnaire to assess niacin-induced cutaneous flushing","volume":"23","author":"Norquist","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t2019041103305396400_b7-0740898","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1742-1241.2008.01739.x","article-title":"Measuring flushing symptoms with extended-release niacin using the Flushing Symptom Questionnaire: results from a randomised placebo-controlled clinical trial","volume":"62","author":"Paolini","year":"2008","journal-title":"Int J Clin Pract"},{"key":"key\n\t\t\t\t2019041103305396400_b8-0740898","first-page":"165","article-title":"The effect of aspirin on niacin-induced cutaneous reactions","volume":"34","author":"Whelan","year":"1992","journal-title":"J Fam Pract"},{"key":"key\n\t\t\t\t2019041103305396400_b9-0740898","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00045391-199506000-00006","article-title":"Low-dose aspirin and ibuprofen reduce the cutaneous reactions following niacin administration","volume":"2","author":"Dunn","year":"1995","journal-title":"Am J Ther"},{"key":"key\n\t\t\t\t2019041103305396400_b10-0740898","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1525-1497.1997.07118.x","article-title":"Effect of two aspirin pretreatment regimens on niacin-induced cutaneous reactions","volume":"12","author":"Jungnickel","year":"1997","journal-title":"J Gen Intern Med"},{"key":"key\n\t\t\t\t2019041103305396400_b11-0740898","first-page":"591","article-title":"Intestinal absorption of aspirin. Influence of pH, taurocholate, ascorbate, and ethanol","volume":"98","author":"Hollander","year":"1981","journal-title":"J Lab Clin Med"},{"key":"key\n\t\t\t\t2019041103305396400_b12-0740898","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.1994.03510330050033","article-title":"A comparison of the efficacy and toxic effects of sustainedvs immediate-release niacin in hypercholesterolemic patients","volume":"271","author":"McKenney","year":"1994","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041103305396400_b13-0740898","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Landray","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041103305396400_b14-0740898","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijcard.2015.05.156","article-title":"Placing HPS2-THRIVE in context using Bayesian analysis","volume":"195","author":"Labos","year":"2015","journal-title":"Int J Cardiol"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/74\/12\/898\/28336220\/ajhp0898.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T15:20:03Z","timestamp":1569424803000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/74\/12\/898\/5102796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,15]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,6,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp160219","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,6,15]]},"published":{"date-parts":[[2017,6,15]]}}}